Financings In Brief
This article was originally published in The Gray Sheet
Executive SummaryDehaier Medical Systems goes public: Developer of medical devices for the Chinese market goes public through a $12 million offering of 1.5 million shares at $8 each, completed April 22. The firm assembles branded products at its Beijing facility from components made by third parties, and also distributes finished products made by other companies. Offerings include x-ray, anesthesia and patient monitoring systems, as well as home respiratory and oxygen products. Proceeds from the initial public offering are tabbed for R&D, marketing, potential acquisitions and working capital. The shares trade on the Nasdaq exchange under the symbol "DHRM." Anderson & Strudwick was placement agent for the offering
You may also be interested in...
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.